Trial no.:
|
PACTR202307885435649 |
Date of Approval:
|
27/07/2023 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
Effect of adding dexmedetomidine as adjuvant to bupivacaine in ultra-sound guided erector spinae plane block for post modified radical mastectomy pain management |
Official scientific title |
Effect of adding dexmedetomidine as adjuvant to bupivacaine in ultra-sound guided erector spinae plane block for post modified radical mastectomy pain management |
Brief summary describing the background
and objectives of the trial
|
Breast cancer is one of the most important medical problems in the female gender, since among every eight women, one will suffer from breast cancer during her lifetime . Acute post-operative pain is very common after breast surgeries which requires adequate pain management. Different peripheral nerve blocks such as paravertebral block had been used as an analgesic option for breast surgeries.
Erector spinae plane block is a newer interfascial plane block first described by Forero et al in 2016 who used it for treating thoracic neuropathic pain by injecting a local anesthetic deep into the erector spinae muscle at the level of T5. Moreover, ESPB is a reasonable option, with clearly identifiable sonographic landmarks and LA needle insertion and injection locations. Later studies have shown that ESPB can provide effective analgesia in breast surgeries.
Ultrasound is a non-invasive visualization technology that helps in capturing the anatomical structure of target tissues, it can help to guide the direction and depth of anesthesia puncture needles, thus reducing the risk of complications.
Adjuvants to local anasthetics, such as opioids, alpha 2 agonists, magnesium and dexamethasone may improve the duration and intensity of peripheral nerve blocks effect. this study aims to assess the effect of adding dexmedetomidine to bupivacaine in US guided erector spinae plane block in modified radical mastectomy surgeries , Using visual analogue score and post-operative narcotics consumption.
|
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Anaesthesia |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Drugs |
Anticipated trial start date |
15/07/2023 |
Actual trial start date |
01/08/2023 |
Anticipated date of last follow up |
05/06/2024 |
Actual Last follow-up date |
05/06/2024 |
Anticipated target sample size (number of participants) |
60 |
Actual target sample size (number of participants) |
60 |
Recruitment status |
Completed |
Publication URL |
|
|